Neoangiogenesis may be most critical marker for melanoma patient prognosis

April 1, 2004

Washington - Ongoing research indicates neoangiogenesis may have a role as both a novel, powerful prognostic factor for melanoma and an important target for therapeutic strategies aiming to reduce the risk for metastasis, said Robert J. Friedman, M.D., M.Sc.